{"id":410968,"date":"2025-11-14T13:30:00","date_gmt":"2025-11-14T12:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=410968"},"modified":"2025-10-27T17:05:30","modified_gmt":"2025-10-27T16:05:30","slug":"evitar-a-armadilha-do-nocebo-com-biossimilares-de-natalizumab","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/evitar-a-armadilha-do-nocebo-com-biossimilares-de-natalizumab\/","title":{"rendered":"Evitar a armadilha do nocebo com biossimilares de natalizumab"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Os anticorpos monoclonais, como o natalizumab, s\u00e3o indispens\u00e1veis para o tratamento da esclerose m\u00faltipla. Um primeiro biossimilar recentemente autorizado \u00e9 clinicamente equivalente, como demonstraram os estudos. No entanto, na pr\u00e1tica, as reservas s\u00e3o generalizadas. Os doentes associam erradamente pre\u00e7os mais baixos a uma qualidade inferior. Estas expectativas negativas provocam o efeito nocebo. Este manifesta-se atrav\u00e9s de queixas subjectivas ou da interrup\u00e7\u00e3o do tratamento, o que p\u00f5e em causa o sucesso terap\u00eautico.     <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fevitar-a-armadilha-do-nocebo-com-biossimilares-de-natalizumab%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Os anticorpos monoclonais, como o natalizumab, s\u00e3o indispens\u00e1veis para o tratamento da esclerose m\u00faltipla. Um primeiro biossimilar recentemente autorizado \u00e9 clinicamente equivalente, como demonstraram os estudos. No entanto, na pr\u00e1tica,&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/pt-pt\/a-minha-conta\/pacotes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/pt-pt\/iniciar-sessao\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fpt-pt%2Fevitar-a-armadilha-do-nocebo-com-biossimilares-de-natalizumab%2F\">Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":410971,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Esclerose m\u00faltipla","footnotes":""},"category":[11551,11521,11453,11524,11374,11481],"tags":[70667,34314,49148],"powerkit_post_featured":[],"class_list":["post-410968","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-pt","category-estudos","category-farmacologia-e-toxicologia","category-formacao-continua","category-neurologia-pt-pt","category-psiquiatria-e-psicoterapia","tag-biossimilares","tag-natalizumab-pt-pt","tag-nocebo-pt-pt","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-01 10:15:09","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":410979,"slug":"evitar-la-trampa-del-nocebo-con-los-biosimilares-de-natalizumab","post_title":"Evitar la trampa del nocebo con los biosimilares de natalizumab","href":"https:\/\/medizinonline.com\/es\/evitar-la-trampa-del-nocebo-con-los-biosimilares-de-natalizumab\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/410968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=410968"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/410968\/revisions"}],"predecessor-version":[{"id":410972,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/410968\/revisions\/410972"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/410971"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=410968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=410968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=410968"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=410968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}